| Literature DB >> 28945325 |
Ana Belen Araúz1, Diego H Caceres2,3, Erika Santiago1, Paige Armstrong2,4, Susan Arosemena1, Carolina Ramos1, Andres Espinosa-Bode2, Jovanna Borace1, Lizbeth Hayer5, Israel Cedeño5, Brendan R Jackson2, Nestor Sosa6, Elizabeth L Berkow2, Shawn R Lockhart2, Amalia Rodriguez-French1, Tom Chiller2.
Abstract
Candida auris is an emerging multidrug-resistant (MDR) fungus associated with invasive infections and high mortality. This report describes 9 patients from whom C. auris was isolated at a hospital in Panama City, Panama, the first such cases in Central America, and highlights the challenges of accurate identification and methods for susceptibility testing.Entities:
Keywords: zzm321990Candida auriszzm321990; acurate; diagnose; susceptibility
Mesh:
Substances:
Year: 2017 PMID: 28945325 DOI: 10.1111/myc.12709
Source DB: PubMed Journal: Mycoses ISSN: 0933-7407 Impact factor: 4.377